Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMalvern Intl Regulatory News (MLVN)

Share Price Information for Malvern Intl (MLVN)

Share Price is delayed by 15 minutes
Get Live Data
22.00    0.00 (0.00%)
Bid:
21.00
Ask:
23.00
Spread: 2.00 (9.524%)
Market Cap: £7.36m
MLVN Live PriceLast checked at - London Stock Exchange

Intraday Malvern Intl Share Chart

Loan Note Conversion and Issue of Equity

13 Jun 2018 09:45

RNS Number : 2566R
Malvern International PLC
13 June 2018
 

13 June 2018

 

MALVERN INTERNATIONAL PLC

("Malvern" or the "Company")

 

Loan Note Conversion

Issue of Equity

Holdings in Company 

 

Malvern International plc (AIM: MLVN), the global learning and skills development partner, has been informed by KSP Investment Pte Limited ("KSP") that KSP has distributed 7,953,672 ordinary shares of 1p each in Malvern ("Ordinary Shares) and £328,102 of its convertible loan notes in Malvern (which are convertible into Ordinary Shares of Malvern at a price of 5 pence per share) to Mr Ho Peng Cheong, a director and shareholder of KSP, who is now leaving KSP (the "Distribution").

 

In addition, KSP has given notice to convert £540,000 of its remaining convertible loan notes into 10,800,000 new Ordinary Shares at an exercise price of 5 pence per share (the "Loan Note Conversion"). Following the Distribution and Loan Note Conversion, KSP holds £231,898 of convertible loan notes and 38,654,445 Ordinary Shares, representing 17.2 per cent. of Malvern's issued ordinary share capital.

Malvern has issued and allotted 10,800,000 new Ordinary Shares each pursuant to the Loan Note Conversion. Application has been made for the 10,800,000 new Ordinary Shares to be admitted to trading on AIM ("Admission"). Dealings are expected to commence on 19 June 2018.

In accordance with the provisions of the Disclosure and Transparency Rules of the Financial Conduct Authority, the Company confirms that following this Loan Note Conversion its issued share capital comprises 224,988,333 Ordinary Shares of 1 pence each. All of the Ordinary Shares have equal voting rights and none of the Ordinary Shares are held in Treasury. The total number of voting rights in the Company is therefore 224,988,333. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure and Transparency Rules.

This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

For further information please contact:

 

Malvern International Plc

www.malverninternational.com

Dr Sam Malafeh - Chief Executive Officer

Via Walbrook PR

Navin Khattar - Non-Executive Director

malvern@walbrookpr.com

WH Ireland (NOMAD & Broker)

www.whirelandcb.com

Mike Coe / Ed Allsopp

+44 117 945 3470

Walbrook PR

+44 20 7933 8780

Tom Cooper / Paul McManus

+44 797 122 1972

tom.cooper@walbrookpr.com

 

 

Notes to Editors:

Malvern International is a global learning and skills development partner preparing students and learners to meet the demands of a professional life. Courses are delivered on sites in London, Singapore, and Malaysia; with the option of studying across multiple campus' over the duration of the same course; and online through the Malvern Online Academy - making step change education accessible while taking part in the learner's journey to success.

Courses include:

· Certificate, Diploma and pre-University programs;

· University degree and post-graduate programs;

· Courses for professional examinations;

· Tuition services for secondary school students and English language teaching.

 

Established in the 1980's and admitted to AIM in 2004, Malvern employs approximately 250 people and delivers a wide range of courses. Malvern's growth strategy is driven by organic growth initiatives complemented by strategic acquisitions. For further investor information go to www.malverninternational.com www.walbrookpr.com/malvern 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCGGUWCQUPRURW
Date   Source Headline
17th Jun 202610:26 amRNSDirector/PDMR Shareholding
17th Jun 20267:00 amRNSAppointment of Chief Financial Officer
16th Jun 20267:00 amRNSHolding(s) in Company
9th Apr 20265:23 pmRNSDirector/PDMR Shareholding
8th Apr 20264:08 pmRNSDirector/PDMR Shareholding
31st Mar 20265:24 pmRNSResult of AGM
26th Mar 20261:43 pmRNSBoard Changes
10th Mar 20263:37 pmRNSHolding(s) in Company
10th Mar 20263:37 pmRNSHolding(s) in Company
9th Mar 20262:39 pmRNSHolding(s) in Company
9th Mar 20262:39 pmRNSHolding(s) in Company
9th Mar 20262:31 pmRNSHolding(s) in Company
6th Mar 20262:41 pmRNSNotice of AGM
5th Mar 202611:45 amRNSResult of GM and Subscription
3rd Mar 202611:17 amRNSIssue of Warrants
3rd Mar 20267:00 amRNSFinal Results
24th Feb 20267:00 amRNSResult of Retail Offer
23rd Feb 20262:04 pmRNSHolding(s) in Company
17th Feb 202612:00 pmRNSLaunch of Retail Offer
17th Feb 202611:25 amRNSResult of Placing
17th Feb 20267:00 amRNSFundraise of approximately £2.0 million
16th Feb 20267:00 amRNSUpdate on ELT operations
28th Jan 20267:00 amRNSContract win: London Metropolitan University
27th Jan 20265:19 pmRNSHolding(s) in Company
9th Oct 20254:02 pmRNSDirector/PDMR Shareholding
3rd Oct 20254:05 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSInterim results
11th Sep 20257:00 amRNSNotice of interim results and change of year end
17th Jul 20257:00 amRNSNew five-year Partnership
30th Jun 20258:32 amRNSHolding(s) in Company
30th Jun 20257:00 amRNSHolding(s) in Company
27th Jun 202512:51 pmRNSHolding(s) in Company
27th Jun 20259:48 amRNSHolding(s) in Company
11th Jun 202511:24 amRNSResult of AGM
11th Jun 20257:00 amRNSTrading update
19th May 20257:00 amRNSNotice of AGM
16th May 20257:00 amRNSUEL: One-year contract secured
12th May 20257:00 amRNSFinal Results
17th Apr 20259:12 amRNSIssue of Warrants
6th Feb 20257:01 amRNSTrading update
6th Feb 20257:00 amRNSNew Partnership – University of Cumbria
20th Jan 20254:04 pmRNSHolding(s) in Company
17th Jan 20257:00 amRNSNew Partnership - University of Wolverhampton
28th Oct 202410:06 amRNSPCA dealing
15th Oct 20242:09 pmRNSDirector Dealing
30th Sep 20249:57 amRNSDirector Dealing
27th Sep 20243:48 pmRNSDirector Dealing
26th Sep 20247:00 amRNSInterim Results
27th Aug 20247:00 amRNSTrading update
15th Jul 20247:00 amRNSChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.